Central labs receive 300 cough syrup samples

NEW DELHI : Government laboratories have received around 300 cough syrup samples for quality testing after the embarrassment of toxic syrups causing deaths abroad.

Indian-made cough syrups have been linked to the death of dozens of children in Uzbekistan and Gambia, prompting the government to tighten the export policy for cough syrups. It is now mandatory to test before supplying to other countries.

As of 4 July, Central labs in Chennai, Mumbai, Kolkata, Ghaziabad (UP), Chandigarh, Gujarat and Jammu had received samples.

On the other hand, government labs in Karnataka, Kerala, Bhopal, Maharashtra, and Uttarakhand, Hyderabad and Guwahati are yet to receive any. The drug regulator has issued an alert to all manufacturers not to over-burden one particular lab for testing.

India, the largest provider of generic drugs globally, exported cough syrups worth $17.6 billion in 2022-23 as against $17 billion in 2021-22. India’s pharma export body Pharmexcil has over 2,000 manufacturers registered with it, and most are manufacturing cough syrups. Queries sent to the health ministry spokesperson did not elicit any response.

Related Posts

  • Pharma
  • June 18, 2025
  • 99 views
Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

Glenmark Pharmaceuticals said that the United States’ Food and Drug Administration (FDA) has concluded inspection of its manufacturing facility in Monroe, North Carolina. Glenmark Pharmaceuticals said that the United States’…

  • Pharma
  • June 18, 2025
  • 88 views
ED conducts searches across six States in drug trafficking case

The Enforcement Directorate on Tuesday conducted searches at 15 locations, including the premises of five pharmaceutical companies, across six States in connection with a drug trafficking case registered in Punjab.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

ED conducts searches across six States in drug trafficking case

ED conducts searches across six States in drug trafficking case

Gurugram: Teen dies after ‘friendly’ blow to chest; hospital role under scanner

Gurugram: Teen dies after ‘friendly’ blow to chest; hospital role under scanner

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base